Expression and clinical significance of syndecan-1 and heparanase in renal cell carcinoma

TU Xiang-an,QIU Shao-peng,DENG Chun-hua,LV Zi-li,DAI Yu-ping,CHEN Ling-wu,CHEN Wei,ZHENG Ke-li
DOI: https://doi.org/10.3969/j.issn.1005-8982.2008.06.016
2008-01-01
Abstract:[Objective] To study the expression of syndecan-1 and heparanase protein in renal cell carcinoma and the relationship with development,progression and metastasis of carcinoma. [Methods] Immunohistochemical technique was used to detect the expression of syndecan-1 and heparanase protein in 62 cases of renal cell carcinoma. [Results] The positive protein expression of syndecan-1 was 50% (31/62). The syndecan-1 protein expression was correlated with the pathological type,clinical stage and lymph node metastasis (P <0.01). The positive protein expression of heparanase was 24.2% (15/62). The heperanase protein expression was correlated with the pathological type,clinical stage and lymph node metastasis (P <0.01). The positive protein co-expression of syndecan-1 and heperanase was correlated with the pathological type,clinical stage and lymph node metastasis (P <0.01). [Conclusions] Co-expression of syndecan-1and heparanase protein might serve as marker of the prognosis of renal cell carcinoma.
What problem does this paper attempt to address?